The Effects of Bindarit in Preventing Stent Restenosis

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
The main study objective is to assess the efficacy and safety of different bindarit dosages compared to placebo in preventing restenosis, in patients submitted to coronary stenting and using a bare metal stent (Vision BMS, by Abbott).
Epistemonikos ID: d9cebab5f982b33f51fc6dbcd6bfb1436a7a9b82
First added on: May 06, 2024